References from Dapsone-controlled leukocytoclastic vasculitis during continued infliximab therapy for Crohn disease. Local targets link to admitted publications; unresolved targets remain external evidence.
No reference evidence is available for this admitted work.
References for Dapsone-controlled leukocytoclastic vasculitis during continued infliximab therapy for Crohn disease | ResearchHub - ResearchHub
